News tagged with paclitaxel
Related topics: breast cancer , cancer , cancer cells , chemotherapy , ovarian cancer
ASCO: Trametinib improves survival in metastatic melanoma
(HealthDay) -- For patients with metastatic melanoma with activating mutations in serine-threonine protein kinase B-RAF (BRAF), treatment with the oral selective MEK inhibitor trametinib is associated with ...
Cancer
Jun 05, 2012 |
not rated yet |
0
Older drug for advanced breast cancer beat newer, pricier meds
(HealthDay) -- Even in the field of cancer treatment, sometimes newer isn't necessarily better.
Cancer
Jun 04, 2012 |
not rated yet |
0
|
Antidepressant helps relieve pain from chemotherapy, study finds
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an ...
Cancer
Jun 04, 2012 |
not rated yet |
0
|
Pre-op chemoradiotherapy ups survival in esophageal cancer
(HealthDay) -- For patients with esophageal or esophagogastric-junction cancer, treatment with neoadjuvant chemoradiotherapy followed by surgical resection is associated with improved survival compared with ...
Cancer
May 31, 2012 |
not rated yet |
0
Study examines drug regimen for the treatment of non-small cell lung cancer among older patients
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients ...
Cancer
Apr 17, 2012 |
not rated yet |
0
Good long-term outcomes for drug-eluting stents
(HealthDay) -- Meta-analysis of randomized clinical trials (RCTs) suggests that drug-eluting stents (DESs) significantly reduce repeat revascularizations, with no increase in stent thrombosis (ST), mortality, ...
Cardiology
Apr 04, 2012 |
4 / 5 (1) |
0
|
Drug combination may provide option to patients with NSCLC ineligible for bevacizumab
A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according to data presented at the AACR Annual ...
Cancer
Apr 03, 2012 |
not rated yet |
0
The Cardiovascular Research Foundation announces initiation of HORIZONS-AMI II Clinical Trial
The Cardiovascular Research Foundation (CRF) today announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in ...
Cardiology
Mar 27, 2012 |
not rated yet |
0
Drug-Eluting stents reduce risk of thrombosis
(HealthDay) -- Cobalt-chromium everolimus eluting stents (CoCr-EES) are associated with a significantly lower rate of stent thrombosis within two years of implantation, compared with other bare-metal and drug-eluting ...
Cardiology
Mar 23, 2012 |
not rated yet |
0
|
Combination therapy may enhance gemcitabine activity
Oncologists who treat patients with pancreatic cancer may be one step closer to understanding why gemcitabine, the only currently available treatment, works in some cases but not in others, according to a paper in Cancer Di ...
Cancer
Feb 28, 2012 |
3 / 5 (2) |
0
Drug-eluting balloons are a promising tool in treatment of narrowed metal stents
A drug-coated balloon inserted in a narrowed bare metal stent is a promising therapy for restoring blood flow, according to research (Abstract 10244) presented at the American Heart Association's Scientific Sessions 2011.
Cardiology
Nov 16, 2011 |
not rated yet |
0
Results of the ROTAXUS trial reported at TCT 2011
A clinical trial testing the efficacy of rotational atherectomy (or rotablation, a process of drilling through plaque deposits) prior to implantation of a drug-eluting stent found that the process was not superior to standard ...
Cardiology
Nov 11, 2011 |
not rated yet |
0
Gene silencing paves way to new treatments for breast cancer
(Medical Xpress) -- Cancer Research UK scientists have discovered that switching off a gene called CERT makes breast cancer cells more sensitive to a range of drugs. The research is published in the Journal of Pathology.
Cancer
Oct 21, 2011 |
not rated yet |
0
Marijuana component could ease pain from chemotherapy drugs
A chemical component of the marijuana plant could prevent the onset of pain associated with drugs used in chemo therapy, particularly in breast cancer patients, according to researchers at Temple University's School of Pharmacy.
Medications
Oct 06, 2011 |
5 / 5 (2) |
0
|
Study points to way of improving chemotherapy response
(Medical Xpress) -- Blocking key proteins could improve response to a common chemotherapy drug, suggests an Oxford University-led study which used cancer cells grown in the lab.
Cancer
Sep 02, 2011 |
5 / 5 (2) |
0
|
